For oral administration. Shake the bottle well before use. Can be taken with or without food, but taking with food may reduce gastrointestinal upset. Use the provided measuring device for accurate dosing.

Deflazacort is a glucocorticoid with anti-inflammatory and immunosuppressive properties. It binds to specific glucocorticoid receptors in the cytoplasm, leading to the formation of a steroid-receptor complex. This complex translocates into the nucleus, modulating gene expression by activating or inhibiting the transcription of various genes involved in inflammatory and immune responses. This results in decreased production of inflammatory mediators, reduced leukocyte migration, and suppression of immune cell function.

• •Systemic fungal infections
• •Hypersensitivity to deflazacort or any components of the suspension
• •Administration of live or live-attenuated vaccines during treatment (unless otherwise advised by physician)

Store below 30°C in a dry place, away from light. Keep out of reach of children. Do not freeze.

Symptoms of acute overdose are unlikely to occur with Deflazacort due to its unique pharmacokinetic profile. However, chronic overdose may lead to Cushingoid features, muscle weakness, and adrenal suppression. Treatment is supportive; gradual withdrawal is usually recommended.

Use during pregnancy only if the potential benefit outweighs the potential risk to the fetus. Corticosteroids are excreted in breast milk; caution should be exercised when administered to a nursing mother. Consult a doctor.